Literature DB >> 14946317

The assay of hypertensin from the arterial blood of normotensive and hypertensive human beings.

J R KAHN, L T SKEGGS, N P SHUMWAY, P E WISENBAUGH.   

Abstract

Hypertensin has been assayed in the blood of patients with normal blood pressure and in those with essential hypertension in both the benign and malignant phases. 250 ml. samples of arterial blood were obtained, chemically purified, and concentrated to a volume of 1 ml. These extracts were then assayed in anesthetized rats. The concentrations of hypertensin in the blood of patients with the malignant phase of essential hypertension were found to be greatly increased. The concentrations of hypertensin found in patients with benign hypertension had a moderate degree of overlapping with those found in the normotensive group, but the mean concentration of hypertensin in the former group was twice that of the controls. Although these results are statistically significant, the amounts of hypertensin recovered in the benign group are so small that no conclusions can be drawn as to its effectiveness in producing vasoconstriction in these patients.

Entities:  

Keywords:  ANGIOTONIN/in blood; HYPERTENSION

Mesh:

Substances:

Year:  1952        PMID: 14946317      PMCID: PMC2212091          DOI: 10.1084/jem.95.6.523

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  The isolation of hypertensin from the circulating blood of normal dogs with experimental renal hypertension by dialysis in an artificial kidney.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  Circulation       Date:  1951-03       Impact factor: 29.690

2.  The isolation of hypertensin from the circulating blood of dogs by dialysis in an artificial kidney.

Authors:  J R KAHN; L T SKEGGS; N P SHUMWAY
Journal:  Circulation       Date:  1950-09       Impact factor: 29.690

3.  The isolation and assay of hypertensin from blood.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1952-03       Impact factor: 14.307

  3 in total
  32 in total

1.  ANGIOTENSIN AND RENO-PORTAL ANASTOMOSIS.

Authors:  M J CHAMBERLAIN; N L BROWSE; D G GIBSON; J A GLEESON
Journal:  Br Med J       Date:  1964-12-12

Review 2.  [ALDOSTERONE AND ALDOSTERONISM. NEW RESULTS AND EXPERIENCES].

Authors:  H P WOLFF
Journal:  Klin Wochenschr       Date:  1964-08-01

3.  PLASMA RENIN CONCENTRATION IN HUMAN HYPERTENSION. 1. RELATIONSHIP BETWEEN RENIN, SODIUM, AND POTASSIUM.

Authors:  J J BROWN; D L DAVIES; A F LEVER; J I ROBERTSON
Journal:  Br Med J       Date:  1965-07-17

4.  STUDIES ON THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS.

Authors:  J GENEST; R BOUCHER; J DE CHAMPLAIN; R VEYRAT; M CHRETIEN; P BIRON; G TREMBLAY; P ROY; P CARTIER
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

5.  THE RELATIONSHIP OF ANGIOTENSIN TO RENAL HYPERTENSION.

Authors:  R E MORRIS; P R ROBINSON; G A SCHEELE
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

6.  [Studies on serum angiotensinase. II. Clinical results in hypertension and liver diseases].

Authors:  D KLAUS; H KAFFARNIK; H PFEIL
Journal:  Klin Wochenschr       Date:  1963-04-15

7.  Plasma angiotensinase activity in patients with hypertension and edema.

Authors:  R B HICKLER; D P LAULER; G W THORN
Journal:  J Clin Invest       Date:  1963-05       Impact factor: 14.808

8.  Humoral stimulation of adrenal cortical secretion.

Authors:  J R BLAIR-WEST; J P COGHLAN; D A DENTON; J R GODING; J A MUNRO; R E PETERSON; M WINTOUR
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

9.  Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion.

Authors:  C C CARPENTER; J O DAVIS; C R AYERS
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

10.  Juxtaglomerular cell counts and human hypertension.

Authors:  C TURGEON; S C SOMMERS
Journal:  Am J Pathol       Date:  1961-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.